Special Issue "Diabetic Retinopathy: Mechanisms underlying Pathophysiology and Therapies"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 June 2019
Dr. Peter Koulen
Departments of Ophthalmology and Basic Medical Science, School of Medicine, University of Missouri-Kansas City, Kansas City, USA
Website | E-Mail
Interests: neuroscience; physiology of the retina and central nervous system; mechanisms of neurodegenerative diseases; calcium signaling; electrophysiology
The identification of mechanisms underlying the pathophysiology and therapies of diabetic retinopathy continues to be an area of significant research efforts, attracting scientists from a diverse range of fields, including neuroscience, pharmacology, and medicinal chemistry among several others. With the ultimate goal to generate intervention strategies that slow or even reverse structural and functional degeneration of the retina and that attenuate or eliminate vascular complications input from numerous fields, such as neurology, ophthalmology, and endocrinology appears critically needed as effective therapies for diabetic retinopathy are lacking.
Research efforts towards treating or curing diabetic retinopathy are characteristic for how clinical practice, basic and translational research inform each other and how such interactions can result in novel therapeutic strategies of high clinical relevance. Recent methodological advances in synthetic and medicinal chemistry, mass spectrometry, proteomics, drug target discovery and drug development have generated significant developments in this field. Therefore, this Special Issue invites manuscript submissions, namely research and review papers, targeting the gamut of methodological and scientific innovation in this field. Of specific interest to this special issue are papers focused on the discovery and mechanistic characterization of novel drug targets, signaling pathways, and mechanisms of action as they are relevant for diabetic retinopathy. These contributions can be general and broad in their basic science and translational research focus or highly focused on specific research models related to structural and functional degeneration of the retina and vascular complications.
Round 1 deadline: 17 October 2018.
Dr. Peter Koulen
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- diabetic macular edema
- proliferative and non-proliferative diabetic retinopathy
- therapy development